What patients and families need to know
The Children's Research Institute
Institutional Biosafety Committee (IBC)
The Children’s National Institutional Biosafety Committee (IBC) acts as the institutional review body for all research activities utilizing recombinant DNA technology as required and outlined in the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines).
The IBC is charged with reviewing recombinant DNA research proposals as well as providing researchers guidance for conducting their recombinant DNA studies in a manner that minimizes exposure risk for research personnel and the environment. Before any research involving recombinant DNA can be initiated it must have received IBC review and approval.
The IBC meets regularly to discuss and review new and active recombinant DNA protocols. These meetings are open to the public. If you would like to participate in a meeting please contact the IBC administrator for more information and schedules.
Research Facility & Biosafety Director